Synairgen (LON:SNG) Trading Down 0.2% – What’s Next?

Shares of Synairgen plc (LON:SNG) traded down 0.2% during mid-day trading on Friday . The stock traded as low as GBX 4.31 ($0.05) and last traded at GBX 4.39 ($0.06). 26,786 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 316,815 shares. The stock had previously closed at GBX 4.40 ($0.06).

Synairgen Price Performance

The firm has a 50-day moving average of GBX 4.47 and a 200-day moving average of GBX 4.54. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The firm has a market capitalization of £8.84 million, a P/E ratio of -146.33 and a beta of -2.23.

About Synairgen

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.